$118 Million is the total value of New England Research & Management, Inc.'s 159 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VLO | New | Valerocs | $673,000 | – | 10,500 | +100.0% | 0.57% | – |
| FLTX | New | FleetMatics Group PLCcs | $635,000 | – | 15,600 | +100.0% | 0.54% | – |
| HBI | New | Hanesbrands, Inc.cs | $612,000 | – | 21,600 | +100.0% | 0.52% | – |
| HRS | New | Harriscs | $611,000 | – | 7,850 | +100.0% | 0.52% | – |
| PANW | New | Palo Alto Networkscs | $592,000 | – | 3,629 | +100.0% | 0.50% | – |
| SNA | New | Snap-On Toolscs | $495,000 | – | 3,150 | +100.0% | 0.42% | – |
| AMWD | New | American Woodmark Corporationcs | $483,000 | – | 6,475 | +100.0% | 0.41% | – |
| IFF | New | Int'l Flvrs & Frag.cs | $478,000 | – | 4,200 | +100.0% | 0.41% | – |
| MPC | New | Marathon Petroleumcs | $476,000 | – | 12,800 | +100.0% | 0.40% | – |
| TYL | New | Tyler Techcs | $383,000 | – | 2,976 | +100.0% | 0.33% | – |
| LB | New | L Brands Inccs | $364,000 | – | 4,150 | +100.0% | 0.31% | – |
| REGN | New | Regeneron Pharmaceuticalscs | $351,000 | – | 975 | +100.0% | 0.30% | – |
| AMSG | New | Amsurg Corpcs | $328,000 | – | 4,400 | +100.0% | 0.28% | – |
| LEN | New | Lennarcs | $278,000 | – | 5,750 | +100.0% | 0.24% | – |
| AMZN | New | Amazon, Inc.cs | $261,000 | – | 440 | +100.0% | 0.22% | – |
| EXPE | New | Expediacs | $232,000 | – | 2,150 | +100.0% | 0.20% | – |
| ALK | New | Alaska Aircs | $228,000 | – | 2,775 | +100.0% | 0.19% | – |
| VZ | New | Verizon Comm.cs | $226,000 | – | 4,183 | +100.0% | 0.19% | – |
| IMPV | New | Imperva Inccs | $202,000 | – | 4,000 | +100.0% | 0.17% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-04-06
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Church and Dwight | 40 | Q3 2023 | 5.1% |
| Johnson & Johnson | 40 | Q3 2023 | 3.9% |
| Cisco Systems | 40 | Q3 2023 | 3.4% |
| Kimberly-Clark | 40 | Q3 2023 | 2.9% |
| Apple Computer | 40 | Q3 2023 | 3.4% |
| Exxon Mobil | 40 | Q3 2023 | 2.9% |
| Pfizer | 40 | Q3 2023 | 2.3% |
| Microsoft | 40 | Q3 2023 | 2.8% |
| CSX Corp | 40 | Q3 2023 | 2.2% |
| Merck | 40 | Q3 2023 | 1.9% |
View New England Research & Management, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-16 |
| 13F-HR | 2024-02-06 |
| 13F-HR | 2023-10-10 |
| 13F-HR | 2023-07-05 |
| 13F-HR | 2023-04-06 |
| 13F-HR | 2023-01-09 |
| 13F-HR | 2022-10-06 |
| 13F-HR | 2022-07-20 |
| 13F-HR | 2022-04-20 |
| 13F-HR | 2022-01-05 |
View New England Research & Management, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.